144 related articles for article (PubMed ID: 10405198)
21. Protective effect of TRPV1 against renal fibrosis via inhibition of TGF-β/Smad signaling in DOCA-salt hypertension.
Wang Y; Wang DH
Mol Med; 2011; 17(11-12):1204-12. PubMed ID: 21792478
[TBL] [Abstract][Full Text] [Related]
22. Lovastatin prevents development of hypertension in spontaneously hypertensive rats.
Jiang J; Roman RJ
Hypertension; 1997 Oct; 30(4):968-74. PubMed ID: 9336402
[TBL] [Abstract][Full Text] [Related]
23. Renal AT1 receptor: computerized quantification in spontaneously hypertensive rats and DOCA-salt rats.
Asano N; Ogura T; Mimura Y; Otsuka F; Kishida M; Hashimoto M; Yamauchi T; Makino H
Res Commun Mol Pathol Pharmacol; 1998 May; 100(2):171-80. PubMed ID: 9667071
[TBL] [Abstract][Full Text] [Related]
24. Diuretic and natriuretic responses to ANF in the presence and absence of renal nerves in DOCA-salt hypertensive rats.
Patel KP; Zeigler DW
Clin Exp Hypertens; 1993 Mar; 15(2):257-70. PubMed ID: 8467316
[TBL] [Abstract][Full Text] [Related]
25. Effects of alpha-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats.
Takaoka M; Kobayashi Y; Yuba M; Ohkita M; Matsumura Y
Eur J Pharmacol; 2001 Jul; 424(2):121-9. PubMed ID: 11476758
[TBL] [Abstract][Full Text] [Related]
26. Renal intramedullary infusion of L-arginine prevents reduction of medullary blood flow and hypertension in Dahl salt-sensitive rats.
Miyata N; Cowley AW
Hypertension; 1999 Jan; 33(1 Pt 2):446-50. PubMed ID: 9931145
[TBL] [Abstract][Full Text] [Related]
27. Hemodynamic studies in DOCA-salt hypertensive rats after opening of an arteriovenous fistula.
Huang M; Hester RL; Guyton AC; Norman RA
Am J Physiol; 1992 Jun; 262(6 Pt 2):H1802-8. PubMed ID: 1621839
[TBL] [Abstract][Full Text] [Related]
28. Renal Medullary Overexpression of Sphingosine-1-Phosphate Receptor 1 Transgene Attenuates Deoxycorticosterone Acetate (DOCA)-Salt Hypertension.
Hu G; Xie D; Chen C; Wang W; Li PL; Ritter JK; Li N
Am J Hypertens; 2023 Aug; 36(9):509-516. PubMed ID: 37171128
[TBL] [Abstract][Full Text] [Related]
29. Chronic angiotensin blockade with candesartan cilexetil in DOCA/salt hypertensive rats reduces cardiac hypertrophy and coronary resistance without affecting blood pressure.
Fujita H; Takeda K; Miki S; Morimoto S; Kawa T; Uchida A; Itoh H; Nakata T; Sasaki S; Nakagawa M
Hypertens Res; 1997 Dec; 20(4):263-7. PubMed ID: 9453261
[TBL] [Abstract][Full Text] [Related]
30. Renal protective effects of N-acetyl-Ser-Asp-Lys-Pro in deoxycorticosterone acetate-salt hypertensive mice.
Rhaleb NE; Pokharel S; Sharma U; Carretero OA
J Hypertens; 2011 Feb; 29(2):330-8. PubMed ID: 21052020
[TBL] [Abstract][Full Text] [Related]
31. Prevention of renal cortical ischemia during aortic clamping with prostaglandin E1.
Arbid EJ; Hakaim AG; LaMorte WW; Menzoian JO
Arch Surg; 1995 Mar; 130(3):326-30; discussion 330-1. PubMed ID: 7887802
[TBL] [Abstract][Full Text] [Related]
32. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor.
Hirata Y; Matsuoka H; Suzuki E; Hayakawa H; Sugimoto T; Matsuda Y; Morishita Y; Kangawa K; Minamino N; Matsuo H
Circulation; 1993 Feb; 87(2):554-61. PubMed ID: 8381060
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of soluble guanylyl cyclase in the inner medulla of DOCA-salt hypertensive rats.
Taylor TA; Pollock JS; Pollock DM
Vascul Pharmacol; 2003 Oct; 40(3):155-60. PubMed ID: 13678647
[TBL] [Abstract][Full Text] [Related]
34. Disparate roles of AT2 receptors in the renal cortical and medullary circulations of anesthetized rabbits.
Duke LM; Eppel GA; Widdop RE; Evans RG
Hypertension; 2003 Aug; 42(2):200-5. PubMed ID: 12847115
[TBL] [Abstract][Full Text] [Related]
35. Anakinra reduces blood pressure and renal fibrosis in one kidney/DOCA/salt-induced hypertension.
Ling YH; Krishnan SM; Chan CT; Diep H; Ferens D; Chin-Dusting J; Kemp-Harper BK; Samuel CS; Hewitson TD; Latz E; Mansell A; Sobey CG; Drummond GR
Pharmacol Res; 2017 Feb; 116():77-86. PubMed ID: 27986554
[TBL] [Abstract][Full Text] [Related]
36. Function of the isolated perfused kidneys from young or adult rats with post-DOCA-salt hypertension.
Vanecková I; Kunes J; Jelínek J
Clin Exp Hypertens; 1999 May; 21(4):407-21. PubMed ID: 10369383
[TBL] [Abstract][Full Text] [Related]
37. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.
Matsumura Y; Hashimoto N; Taira S; Kuro T; Kitano R; Ohkita M; Opgenorth TJ; Takaoka M
Hypertension; 1999 Feb; 33(2):759-65. PubMed ID: 10024341
[TBL] [Abstract][Full Text] [Related]
38. Comparison of angiotensin-converting enzyme (ACE), neutral endopeptidase (NEP) and dual ACE/NEP inhibition on blood pressure and resistance arteries of deoxycorticosterone acetate-salt hypertensive rats.
Pu Q; Touyz RM; Schiffrin EL
J Hypertens; 2002 May; 20(5):899-907. PubMed ID: 12011651
[TBL] [Abstract][Full Text] [Related]
39. Selective antagonism of endothelin ET(A) or ET(B) receptor in renal hemodynamics and function of deoxycorticosterone acetate-salt-induced hypertensive rats.
Matsumura Y; Taira S; Kitano R; Hashimoto N; Kuro T
Biol Pharm Bull; 1999 Aug; 22(8):858-62. PubMed ID: 10480326
[TBL] [Abstract][Full Text] [Related]
40. α-MSH analogue attenuates blood pressure elevation in DOCA-salt hypertensive mice.
Rinne P; Penttinen AM; Nordlund W; Ahotupa M; Savontaus E
PLoS One; 2013; 8(8):e72857. PubMed ID: 23977363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
